Clinical characteristics and lipid lowering treatment of patients initiated on proprotein convertase subtilisin-kexin type 9 inhibitors: a nationwide cohort study

por Jensen, Jakob Solgaard, Weeke, Peter Ejvin, Bang, Lia Evi, Høfsten, Dan Eik, Ripa, Maria Sejersten, Schjerning, Anne-Marie, Theilade, Juliane Elizabeth, Køber, Lars Valeur, Gislason, Gunnar Hilmar, Pallisgaard, Jannik
Publicado 2019